Search
for

    Glossary

    Similar Terms

    Learn

    0 / 0 results
    — no results

    Research

    5 / 133 results

    Community Join

    5 / 97 results

      community Insomnia and Finasteride

      in Finasteride/Dutasteride  6 upvotes 4 years ago
      A user reports experiencing insomnia as a side effect of taking finasteride for hair loss, which takes 1 to 2 hours to fall asleep and results in only about 5 hours of sleep per night. They suspect the cause is related to the downregulation of neurosteroids due to finasteride.

      community Does ashwagandha work against finasteride?

      in Finasteride/Dutasteride  3 upvotes 2 weeks ago
      Finasteride may cause insomnia, and ashwagandha is suggested to help with sleep issues without significantly affecting testosterone or DHT levels. Users discuss personal experiences with sleep disturbances and suggest consulting a doctor if side effects persist.

      community CB-03-01 / Breezula Personal Results

      in Treatment  14 upvotes 1 week ago
      The user shared their experience with CB-03-01 (Breezula/Clascoterone) for hair loss, noting reduced shedding and improved hair appearance but experiencing significant sleep disturbances and low energy due to HPA axis suppression. They decided to stop using it due to these side effects and are waiting for GT20029 as an alternative.

      community 2800 FUE Asmed Koray Erdogan Istanbul, complete failure

      in Transplants  287 upvotes 7 months ago
      A user had a failed hair transplant with 2800 FUE grafts at a clinic in Turkey, where finasteride was used, and the procedure was poorly executed by technicians rather than the main surgeon. The user later sought repair from a more experienced doctor, highlighting issues with large clinics that handle multiple patients daily.

      community PP405 Phase 2a press release with early results

      in Research/Science  695 upvotes 8 months ago
      PP405 shows promise in hair regrowth, with 31% of participants experiencing over 20% increase in hair density after 8 weeks. Phase 3 trials are expected in 2026, with potential market availability by 2029-2031.